The modification of PTPIP51 related signaling gives the possibility to influence the associated signaling pathways like the MAPK pathway, NFκB signaling and the calcium homeostasis, which if over-activated or deregulated all lead, to enhanced proliferation, growth, and invasiveness of breast cancer. This evidence concerns the gene RMDN3 and breast carcinoma.